Press release
Global Lung Cancer Therapeutics Market, Size, Share, Analysis Report & Forecast to 2026
The global lung cancer therapeutics market is anticipated to grow at a CAGR of around 8.7% during the forecast period. Lung cancer negatively affects the lungs' potential to deliver oxygen to the bloodstream. It is one of the most commonly diagnosed diseases, and among all cancers, lung cancer has the highest mortality rate in both men and women. The primary risk factor for the development of lung cancer is cigarette smoking. Further rise in the adoption of unhealthy lifestyles among people, growing demand for targeted therapies, and availability of efficient drugs and treatments are also propelling the growth of the market. On the contrary, widespread availability of only essential generic drugs, the presence of limited treatment options, and a large unmet need for diagnosis are expected to be the major factors restraining the overall growth of the lung cancer therapeutics market. However, the increasing rate of approvals in lung cancer therapeutics and the introduction to nanomedicine will be creating an opportunity for the growth of the market.Free Sample Copy @ https://www.omrglobal.com/request-sample/lung-cancer-therapeutics-market
The global Lung Cancer Therapeutics market is segmented based on drugs, therapy, and end-user. Based on drugs, the market is segmented into Platinol, Taxol, Gemzar, Alimta, and others (Iressa, Hycamtin, Gilotrif, Taxotere, Xalkori). Based on therapy, the market is classified into chemotherapy, targeted therapy, immunotherapy, radiation therapy, and others. Further, based on end-user, the market is segregated into multispeciality hospitals and cancer research centers.
A Full Report of Global Lung Cancer Therapeutics Market is Available at:
https://www.omrglobal.com/industry-reports/lung-cancer-therapeutics-market
The global lung cancer therapeutics market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. Due to a high prevalence rate of lung cancer in the region, North America is projected to have a significant share in the global market. For instance, according to the American Lung Association, lung cancer has been diagnosed in approximately 541,000 Americans at some point in their lives. An estimated 234,030 new cases of lung cancer were expected to be diagnosed in 2018, accounting for roughly 13% of all cancer diagnoses. Furthermore, targeted therapies are a rapidly expanding area of cancer research, with researchers studying numerous new targets and drugs in clinical trials, therefore these factors are propelling the market growth in North America.
Global Lung Cancer Therapeutics Market – Segmentation
by Drugs
Platinol
Taxol
Gemzar
Alimta
Others (Iressa, Hycamtin, Gilotrif, Taxotere, Xalkori)
by Therapy
Chemotherapy
Targeted Therapy
Immunotherapy
Radiation Therapy
Others
by End-User
Multispeciality Hospitals
Cancer Research Centers
Global Lung Cancer Therapeutics Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbvie Inc.
Achieve Life Sciences, Inc.
Amgen Inc.
AstraZeneca Plc
Astellas Pharma Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Celldex Therapeutics, Inc
Eisai Co Ltd
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Glaxosmithkline Plc
Helsinn Healthcare S.A.
Novartis International AG
Pfizer, Inc.
Sanofi SA
Teva Pharmaceutical Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lung-cancer-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lung Cancer Therapeutics Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2434474 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…
